For the research project SERENITY – “Towards Cancer Patient Empowerment for Optimal Use of Antithrombotic Therapy at the End of Life”, funded by the European Commission’s HORIZON programme, we are inviting physicians across Europe to participate in a short survey on the management of antithrombotic therapy during the end-of-life care of cancer patients.


If you are interested in participating in the survey, please pre-register using the following link: SERENITY Physician Survey – Pre-registration

Please find comprehensive information on the SERENITY Physician Survey at | Clinical Studies » SERENITY (

For more information on SERENITY, please also visit


more information here